Prognostic Role of Tumor Budding and Worst Pattern of Invasion in Lymph Node Metastasis and Disease-Free Survival in Oral Squamous Cell Cancer Patients: Result from Central India's Regional Cancer Centre
View abstract on PubMed
Summary
This summary is machine-generated.Tumor budding and depth of invasion are key predictors of nodal metastasis in oral squamous cell carcinoma. These factors, along with pattern of invasion, also impact disease-free survival, highlighting their importance in patient prognosis.
Area Of Science
- Oncology
- Pathology
Background
- Oral squamous cell carcinoma (OSCC) is a significant global health concern.
- Accurate prediction of nodal metastasis and disease-free survival is crucial for effective OSCC patient management.
Purpose Of The Study
- To investigate the prognostic value of clinicopathological parameters, specifically pattern of invasion and tumor budding, in OSCC.
- To identify independent predictors of nodal metastasis and disease-free survival in OSCC patients.
Main Methods
- Retrospective analysis of 90 OSCC patients treated surgically.
- Univariate and multivariate logistic regression analyses to assess predictive significance of clinicopathological parameters.
- Kaplan-Meier method and log-rank test for disease-free survival analysis.
Main Results
- Multivariate analysis identified tumor budding, depth of invasion, and perineural invasion as independent predictors of nodal metastasis (p < 0.05).
- Infiltrative pattern of invasion and tumor budding significantly correlated with poorer 3-year disease-free survival (p < 0.05).
- Several factors including grade, T stage, lymphovascular emboli, and pattern of invasion were significant on univariate analysis.
Conclusions
- Tumor budding and worst pattern of invasion are critical prognostic indicators in OSCC.
- These parameters, along with host lymphocyte response, should be incorporated into routine histopathology reporting for OSCC.
- Improved histopathological assessment can enhance risk stratification and guide treatment decisions for OSCC patients.

